Document Detail


+9/+9 Homozygosity of the bradykinin receptor gene polymorphism is associated with reduced fat-free mass in chronic obstructive pulmonary disease.
MedLine Citation:
PMID:  16600946     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
BACKGROUND: The etiology of muscle wasting in chronic obstructive pulmonary disease (COPD) is incompletely understood. We previously showed that the D rather than the I polymorphic variant of the angiotensin-converting enzyme (ACE) gene is associated with preserved quadriceps strength in COPD. If the ACE D allele influences skeletal muscle through increased ACE-related kinin degradation [and reduced activity at the bradykinin type 2 receptor (BK(2)R)], we might expect a similar association with the +9 BK(2)R genotype in this population as well. OBJECTIVE: The objective was to test the hypothesis that the BK(2)R gene polymorphism is a determinant of fat-free mass and quadriceps strength in patients with COPD. DESIGN: In a cross-sectional design we determined BK(2)R genotype, fat-free mass, and quadriceps strength in 110 COPD patients with a mean (+/-SD) predicted forced expiratory volume in 1 s of 34.3 +/- 16.4% and in 104 healthy age-matched control subjects. RESULTS: The mean (+/-SD) fat-free mass index (in kg/m(2)) was significantly lower in 37 patients homozygous for the +9 allele than in carriers of the -9 allele (15.7 +/- 1.8 compared with 16.7 +/- 2.3; P = 0.038); the same pattern was true for quadriceps maximal voluntary force (30.8 +/- 10.4 and 36.4 +/- 12.8 kg; P = 0.02), respectively. No significant effect of BK(2)R genotype on inspiratory muscle strength or on any variable in control subjects was observed. There was no interaction between the effect of the BK(2)R and ACE genotypes on quadriceps strength. CONCLUSIONS: The genotype associated with reduced BK(2)R expression is associated with reduced fat-free mass and quadriceps strength in COPD. However, alterations in the activity at the BK(2)R do not seem to account for the previously identified association of quadriceps strength with ACE genotype.
Authors:
Nicholas S Hopkinson; Kyriacos I Eleftheriou; John Payne; Annabel H Nickol; Emma Hawe; John Moxham; Hugh Montgomery; Michael I Polkey
Related Documents :
1907536 - Prediction of maximum exercise tolerance in patients with copd.
8252956 - Prediction of maximal exercise capacity in obstructive and restrictive pulmonary disease.
17603916 - Prescribing cycle training intensity from the six-minute walk test for patients with copd.
4037536 - Increases in intrathoracic pressure do not explain the rise in left ventricular end-dia...
8783676 - Catecholamines, renin-angiotensin-aldosterone system, and atrial natriuretic peptide at...
1536156 - A study of the cardiac effects of bromochlorodifluoromethane (halon 1211) exposure duri...
Publication Detail:
Type:  Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  The American journal of clinical nutrition     Volume:  83     ISSN:  0002-9165     ISO Abbreviation:  Am. J. Clin. Nutr.     Publication Date:  2006 Apr 
Date Detail:
Created Date:  2006-04-07     Completed Date:  2006-05-18     Revised Date:  2007-08-13    
Medline Journal Info:
Nlm Unique ID:  0376027     Medline TA:  Am J Clin Nutr     Country:  United States    
Other Details:
Languages:  eng     Pagination:  912-7     Citation Subset:  AIM; IM    
Affiliation:
Respiratory Muscle Laboratory, Royal Brompton Hospital, Fulham Road, London SW3 6NP, United Kingdom. n.hopkinson@ic.ac.uk
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Alleles
Case-Control Studies
Cohort Studies
Cross-Sectional Studies
Female
Genotype
Homozygote
Humans
Male
Middle Aged
Muscle, Skeletal / metabolism*,  physiopathology
Peptidyl-Dipeptidase A / genetics
Polymorphism, Genetic*
Pulmonary Disease, Chronic Obstructive / genetics*,  physiopathology*
Receptors, Bradykinin / genetics*,  metabolism*
Respiratory Function Tests
Respiratory Muscles / metabolism,  physiopathology
Grant Support
ID/Acronym/Agency:
//Wellcome Trust
Chemical
Reg. No./Substance:
0/Receptors, Bradykinin; EC 3.4.15.1/Peptidyl-Dipeptidase A

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Dietary choline and betaine assessed by food-frequency questionnaire in relation to plasma total hom...
Next Document:  The Nutrition Academic Award: brief history, overview, and legacy.